News | Stent Grafts | February 14, 2019

Aortic Stent Graft Global Market to Reach $5.4 Billion by 2028

Abdominal aortic stent grafts will remain largest segment due to greater prevalence of abdominal aortic aneurysms

Aortic Stent Graft Global Market to Reach $5.4 Billion by 2028

February 14, 2019 — Abdominal aortic stent grafts will remain the largest segment in the global aortic stent graft market at least through 2028 due to the high prevalence of abdominal aortic aneurysms (AAA) relative to thoracic abdominal aneurysms (TAA), according to a new report from GlobalData. The abdominal segment will reach an estimated $2.8 billion global value by 2028, while the overall global aortic stent graft market is expected to reach $4.5 billion in the same period. This represents a compound annual growth rate of 5.4 percent between 2018 and 2028.

The company’s latest report, ‘Aortic Stent Grafts – Cardiovascular Market Analysis and Forecast Model’ reveals that Asia Pacific will be one of the fastest growing regions at a CAGR of 6.7 percent during the forecast period, with North America and Europe following closely behind at 4.9 percent and 4.6 percent, respectively.

David Brown, medical devices analyst at GlobalData commented, “Advances in stent graft design, such as with fenestrated and branched endografts, continue to expand the eligible patient pool for endovascular repair by addressing increasingly complex aneurysm anatomies.”

Although endovascular repair of aneurysms is a commonly used procedure and is increasingly employed over open repair procedures for the majority of aneurysms, barriers to market growth include the high cost of aortic stent graft devices and the relative lack of long-term outcome benefits versus open aortic repair.

For more information: www.globaldata.com


Related Content

News | Cath Lab

March 14, 2023 — Royal Philips, a global leader in health technology, and the Gibraltar Health Authority, announced they ...

Home March 14, 2023
Home
News | Cath Lab

March 1, 2023 — SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for ...

Home March 01, 2023
Home
News | Cath Lab

May 31, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, announced that the company has received ...

Home May 31, 2022
Home
News | Cath Lab

May 26, 2022 — The U.S. Food and Drug Administration (FDA) has recalled the Dragonfly OpStar Imaging Catheter, and has ...

Home May 26, 2022
Home
News | Cath Lab
April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology ...
Home April 25, 2022
Home
News | Cath Lab
April 18, 2022 – Royal Philips and Oulu University Hospital (Finland) have announced a strategic 10-year partnership ...
Home April 18, 2022
Home
News | Cath Lab
February 16, 2022 – Fremont Bank Foundation recently donated $750,000 to its community partner, St. Rose Hospital ...
Home February 16, 2022
Home
News | Cath Lab
February 14, 2022 — A collaborative effort between The Valley Heart and Vascular Institute’s cardiology team ...
Home February 14, 2022
Home
Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
Home
News | Cath Lab

January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device ...

Home January 04, 2022
Home
Subscribe Now